日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Construction and validation of a regulatory T cells-based classification of renal cell carcinoma: an integrated bioinformatic analysis and clinical cohort study.

构建和验证基于调节性 T 细胞的肾细胞癌分类：一项综合生物信息学分析和临床队列研究

期刊:Cellular Oncology
影响因子:4.8
doi:10.1007/s13402-024-01030-9
Yao Yuntao, Liu Yifan, Lu Bingnan, Ji Guo, Wang Lei, Dong Keqin, Zhao Zihui, Lyu Donghao, Wei Maodong, Tu Siqi, Lyu Xukun, Li Yuanan, Huang Runzhi, Zhou Wang, Xu Guofeng, Pan Xiuwu, Cui Xingang
细胞生物学
肿瘤免疫
发表日期：2025
文献求助 收藏

A Pan-Cancer Analysis of Natriuretic Peptide Receptor 3 (NPR3) with Clinical Cohort and in vitro Validation.

利钠肽受体 3 (NPR3) 的泛癌分析：临床队列和体外验证

期刊:Journal of Inflammation Research
影响因子:4.1
doi:10.2147/JIR.S515347
Liu Yifan, Liu Jiangui, Li Yuanan, Zhao Zihui, Lyu Donghao, Dong Keqin, Wei Maodong, Huang Runzhi, Lu Bingnan, Pan Xiuwu
肿瘤
发表日期：2025
文献求助 收藏

Uncovering the research evolution and hotspots of metabolism in renal cell carcinoma over the last decade

揭示过去十年肾细胞癌代谢研究的演变历程和热点领域

期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2025.1537805
Liu, Yifan; He, Junzhe; Lyu, Donghao; Yang, Xinyue; Zhang, Haoyu; Tu, Siqi; Yao, Yuntao; Wei, Maodong; Li, Yuanan; Zhao, Zihui; Huang, Runzhi; Lu, Bingnan; Xu, Xiao; Pan, Xiuwu
肿瘤
肿瘤免疫
肾癌
代谢
细胞生物学
发表日期：2025
文献求助 收藏

Lymphocyte activation gene 3 served as a potential prognostic and immunological biomarker across various cancer types: a clinical and pan-cancer analysis

淋巴细胞活化基因3可作为多种癌症类型中潜在的预后和免疫学生物标志物：一项临床和泛癌分析

期刊:Clinical & Translational Immunology
影响因子:3.8
doi:10.1002/cti2.70009
Liu, Yifan; Yao, Yuntao; Yang, Xinyue; Wei, Maodong; Lu, Bingnan; Dong, Keqing; Lyu, Donghao; Li, Yuanan; Guan, Wenbin; Huang, Runzhi; Xu, Guofeng; Pan, Xiuwu
细胞生物学
肿瘤
肿瘤免疫
免疫/内分泌
发表日期：2024
文献求助 收藏